Format

Send to

Choose Destination
J Rheumatol. 2016 May;43(5):993-4. doi: 10.3899/jrheum.151347.

Dr. Roubille, et al reply.

Author information

1
Rheumatology Research Fellow, University of Montreal Hospital Research Center (Centre de Recherche du CHUM), Notre-Dame Hospital, Quebec City, Quebec; camille.roubille@gmail.com.
2
Dermatology Resident, Department of Medicine, Dermatology Service, St-Luc Hospital, Quebec City, Quebec;
3
Rheumatology Resident, Sacré-Coeur Hospital of Montreal, University of Montreal, Quebec City, Quebec;
4
Clinical Fellow in Immunodermatology, Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia;
5
Internal Medicine Resident, Division of Rheumatology, University of Alberta, Edmonton, Alberta;
6
Dermatology Resident, Division of Dermatology, University of Toronto, Toronto, Ontario;
7
Internal Medicine Resident, Division of Rheumatology, Western University of Canada, London, Ontario;
8
Dermatologist, Lynde Dermatology, Markham, Ontario;
9
Professor of Rheumatology, Division of Rheumatology, Western University of Canada, London, Ontario;
10
Professor of Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland;
11
Associate Professor of Rheumatology, Division of Rheumatology, University of Alberta, Edmonton, Alberta;
12
Professor of Dermatology, Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia;
13
Associate Professor of Medicine, Centre de Recherche du CHU de Québec, Department of Medicine, Laval University, Quebec City, Quebec;
14
Medical Director, Innovaderm Research, Quebec City, Quebec;
15
Head of Clinical Research Unit, Institut de Rhumatologie de Montréal, Quebec City, Quebec, Canada.
PMID:
27134278
DOI:
10.3899/jrheum.151347

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center